Literature DB >> 29671588

Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.

Richard W Fitch1, Barry B Snider2, Quan Zhou2, Bruce M Foxman2, Anshul A Pandya3, Jerrel L Yakel3, Thao T Olson4, Nour Al-Muhtasib4, Yingxian Xiao4, Kevin D Welch5, Kip E Panter5.   

Abstract

Phantasmidine, a rigid congener of the well-known nicotinic acetylcholine receptor agonist epibatidine, is found in the same species of poison frog ( Epipedobates anthonyi). Natural phantasmidine was found to be a 4:1 scalemic mixture, enriched in the (2a R,4a S,9a S) enantiomer by chiral-phase LC-MS comparison to the synthetic enantiomers whose absolute configurations were previously established by Mosher's amide analysis. The major enantiomer has the opposite S configuration at the benzylic carbon to natural epibatidine, whose benzylic carbon is R. Pharmacological characterization of the synthetic racemate and separated enantiomers established that phantasmidine is ∼10-fold less potent than epibatidine, but ∼100-fold more potent than nicotine in most receptors tested. Unlike epibatidine, phantasmidine is sharply enantioselective in its activity and the major natural enantiomer whose benzylic carbon has the 4a S configuration is more active. The stereoselective pharmacology of phantasmidine is ascribed to its rigid and asymmetric shape as compared to the nearly symmetric conformations previously suggested for epibatidine enantiomers. While phantasmidine itself is too toxic for direct therapeutic use, we believe it is a useful platform for the development of potent and selective nicotinic agonists, which may have value as pharmacological tools.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29671588      PMCID: PMC7142328          DOI: 10.1021/acs.jnatprod.8b00062

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  27 in total

1.  Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors.

Authors:  J E Spang; S Bertrand; G Westera; J T Patt; P A Schubiger; D Bertrand
Journal:  Chem Biol       Date:  2000-07

Review 2.  Central nicotinic receptors: structure, function, ligands, and therapeutic potential.

Authors:  M Novella Romanelli; Paola Gratteri; Luca Guandalini; Elisabetta Martini; Claudia Bonaccini; Fulvio Gualtieri
Journal:  ChemMedChem       Date:  2007-06       Impact factor: 3.466

3.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

4.  Synthesis of phantasmidine.

Authors:  Quan Zhou; Barry B Snider
Journal:  Org Lett       Date:  2010-12-22       Impact factor: 6.005

5.  Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.

Authors:  Scott B Hansen; Gerlind Sulzenbacher; Tom Huxford; Pascale Marchot; Palmer Taylor; Yves Bourne
Journal:  EMBO J       Date:  2005-09-29       Impact factor: 11.598

Review 6.  Desensitized nicotinic receptors in brain.

Authors:  Hai Wang; Xiulan Sun
Journal:  Brain Res Brain Res Rev       Date:  2005-06

7.  Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.

Authors:  V Gerzanich; X Peng; F Wang; G Wells; R Anand; S Fletcher; J Lindstrom
Journal:  Mol Pharmacol       Date:  1995-10       Impact factor: 4.436

8.  An unusual pattern of ligand-receptor interactions for the α7 nicotinic acetylcholine receptor, with implications for the binding of varenicline.

Authors:  Ethan B Van Arnam; Emily E Blythe; Henry A Lester; Dennis A Dougherty
Journal:  Mol Pharmacol       Date:  2013-05-16       Impact factor: 4.436

9.  The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.

Authors:  Yingxian Xiao; Kenneth J Kellar
Journal:  J Pharmacol Exp Ther       Date:  2004-03-11       Impact factor: 4.030

10.  Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent.

Authors:  M Fisher; D Huangfu; T Y Shen; P G Guyenet
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  2 in total

Review 1.  Pyridine alkaloids with activity in the central nervous system.

Authors:  Simon X Lin; Maurice A Curtis; Jonathan Sperry
Journal:  Bioorg Med Chem       Date:  2020-10-16       Impact factor: 3.641

2.  Isolation and Biological Characterization of Homoisoflavanoids and the Alkylamide N-p-Coumaroyltyramine from Crinum biflorum Rottb., an Amaryllidaceae Species Collected in Senegal.

Authors:  Marco Masi; Manoj Koirala; Antonella Delicato; Roberta Di Lecce; Natacha Merindol; Seydou Ka; Matar Seck; Angela Tuzi; Isabel Desgagne-Penix; Viola Calabrò; Antonio Evidente
Journal:  Biomolecules       Date:  2021-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.